Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Kari Poikolainen, research director (kari.poikolainen@stakes.fi)
  1. Finnish Foundation for Alcohol Studies, PO Box 220, FIN-00531, Helsinki, Finland

    Anxiety and depression may be risk factors for using ecstasy

    Ecstasy (3-4 methylenedioxymethamphetamine, MDMA) is a synthetic, psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline. It is neurotoxic for animals and a health risk for humans.1 Most users are young, and use has increased in most European countries where annual survey data are available, now exceeding amphetamine use in some. In Europe recent lifetime experience rates range from 0.4% to 13% among 15-24-year olds; in the United States the rate is 14.8% among 18-25 year olds.2 However, surveys probably underestimate the number of users.3 Ecstasy users often use other illicit drugs,4 raising the question why young people take addictive drugs.

    To become addicted to something, you must first be able to obtain it; then you have to try it, you must instantly like …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL